Search Results - "Rabushko, Elizaveta"

Clinically relevant fusion oncogenes: detection and practical implications by Sorokin, Maksim, Rabushko, Elizaveta, Rozenberg, Julian Markovich, Mohammad, Tharaa, Seryakov, Aleksander, Sekacheva, Marina, Buzdin, Anton

“…Mechanistically, chimeric genes result from DNA rearrangements and include parts of preexisting normal genes combined at the genomic junction site. Some…”
Get full text

RNA Sequencing for Personalized Treatment of Metastatic Leiomyosarcoma: Case Report by Seryakov, Alexander, Magomedova, Zaynab, Suntsova, Maria, Prokofieva, Anastasia, Rabushko, Elizaveta, Glusker, Alexander, Makovskaia, Lyudmila, Zolotovskaia, Marianna, Buzdin, Anton, Sorokin, Maxim

“…Uterine leiomyosarcoma (UL) is a rare malignant tumor that develops from the uterine smooth muscle tissue. Due to the low frequency and lack of sufficient data…”
Get full text

RNA Sequencing Data for FFPE Tumor Blocks Can Be Used for Robust Estimation of Tumor Mutation Burden in Individual Biosamples by Sorokin, Maxim, Gorelyshev, Alexander, Efimov, Victor, Zotova, Evgenia, Zolotovskaia, Marianna, Rabushko, Elizaveta, Kuzmin, Denis, Seryakov, Alexander, Kamashev, Dmitry, Li, Xinmin, Poddubskaya, Elena, Suntsova, Maria, Buzdin, Anton

“…Tumor mutation burden (TMB) is a well-known efficacy predictor for checkpoint inhibitor immunotherapies. Currently, TMB assessment relies on DNA sequencing…”
Get full text

Experimental and Meta-Analytic Validation of RNA Sequencing Signatures for Predicting Status of Microsatellite Instability by Sorokin, Maksim, Rabushko, Elizaveta, Efimov, Victor, Poddubskaya, Elena, Sekacheva, Marina, Simonov, Alexander, Nikitin, Daniil, Drobyshev, Aleksey, Suntsova, Maria, Buzdin, Anton

“…Microsatellite instability (MSI) is an important diagnostic and prognostic cancer biomarker. In colorectal, cervical, ovarian, and gastric cancers, it can…”
Get full text

Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3′ Oncogenes from FFPE Bulk RNA Sequencing Data by Rabushko, Elizaveta, Sorokin, Maxim, Suntsova, Maria, Seryakov, Alexander P, Kuzmin, Denis V, Poddubskaya, Elena, Buzdin, Anton A

“…Drugs targeting receptor tyrosine kinase (RTK) oncogenic fusion proteins demonstrate impressive anti-cancer activities. The fusion presence in the cancer is…”
Get full text

A New Approach of Detecting ALK Fusion Oncogenes by RNA Sequencing Exon Coverage Analysis by Zakharova, Galina, Suntsova, Maria, Rabushko, Elizaveta, Mohammad, Tharaa, Drobyshev, Alexey, Seryakov, Alexander, Poddubskaya, Elena, Moisseev, Alexey, Smirnova, Anastasia, Sorokin, Maxim, Tkachev, Victor, Simonov, Alexander, Guguchkin, Egor, Karpulevich, Evgeny, Buzdin, Anton

“…Background: In clinical practice, various methods are used to identify ALK gene rearrangements in tumor samples, ranging from “classic” techniques, such as…”
Get full text

RNA Sequencing for Personalized Treatment of Metastatic Leiomyosarcoma: Case Report by Seryakov, Alexander, Magomedova, Zaynab, Suntsova, Maria, Prokofieva, Anastasia, Rabushko, Elizaveta, Glusker, Alexander, Makovskaia, Lyudmila, Zolotovskaia, Marianna, Buzdin, Anton, Sorokin, Maxim

“…Uterine leiomyosarcoma (UL) is a rare malignant tumor that develops from the uterine smooth muscle tissue. Due to the low frequency and lack of sufficient data…”
Get full text